India-made COVID-19 vaccine Covaxin, developed by the biotechnology company Bharat Biotech, on Wednesday was approved by the World Health Organization (WHO) for emergency use.
According to an India Today report, the WHO's technical advisory group has recommended the Emergency Use Listing status for Bharat Biotech's Covaxin, reports Xinhua.
Earlier on Monday, Australia's medicines and medical devices regulator had formally recognised Covaxin, as the country's border was reopened for the first time in nearly 20 months, said the report.